Clinical TrialsSearch results
Number of results: 1085
Recruiting
- An open-label randomized controlled trial of MCS-612 in Japanese myopic children
- Mild and moderate myopia and myopic astigmatism
- Nakamura Kikue
- 2023-06-25
Recruiting
- An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma
- previously untreated CD20-positive large B-cell lymphoma (LBCL)
- Aurelien Berthier
- 2024-02-27
Recruiting
- An Open-label Study to Evaluate the Safety and Pharmacokinetics of Migalastat HCl in Subjects with Fabry Disease and Renal dysfunctions
- Fabry Disease
- Koh KyuBum
- 2022-12-02
Recruiting
- An open-label, uncontrolled study to evaluate the safety and immunogenicity of FPP003 in subjects with axial spondyloarthritis (phase IIa study)
- Axial spondyloarthritis (ankylosing spondylitis and axial spondyloarthritis not meeting radiographic
- Tsuji Shigeyoshi
- 2023-09-04
Recruiting
- Anamorelin study for gastrectomized patients with unresectable advanced or recurrent gastric cancer
- Unresectable advanced or recurrent gastric cancer and cachexia
- Doki Yuichiro
- 2021-10-13
Recruiting
- APPETIZE-HF trial
- Chronic heart failure with loss of appetite
- Seo Masahiro
- 2023-01-30
Recruiting
- Chemo-radiation for locally advanced biliary cancer
- Unresectable and locally advanced biliary cancer
- Osaka University, Graduate School of Medicine, GE Surgery
- 2008-06-22
Recruiting
- Chemoradiation therapy on conversion surgery for unresectable locally advanced pancreatic cancer
- Pancreatic ductal adenocarcinoma
- Kobayashi Shogo
- 2022-02-03
Recruiting
- Clinical pharmacology study of satralizumab in patients with anti-AQP4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-IgG + NMOSD)
- Neuromyelitis optica spectrum disorders(NMOSD)
- Okuno Tatsusada
- 2023-04-10
Recruiting
- Clinical Study of OP-07 for Delayed Methotrexate Elimination with Methotrexate-Leucovorin Rescue Therapy
- Subjects with delayed MTX elimination after MTX/LV rescue therapy
- Watanabe Tatsuo
- 2022-05-25